2002年毕业于延边大学药学院，获学士学位；2006年获延边大学药学院药剂学硕士学位；2010年获日本冈山大学药学部临床药理学博士学位

2011年到大连医科大学任教

1. 国家自然科学基金面上项目，81874324，转运体介导哌拉西林/他唑巴坦及亚胺培南/西司他丁发生增效减毒相互作用的分子药代动力学机制，2019/01-2022.12，85万元，在研，参加。 2. 国家自然科学基金面上项目，81473280，PEPT和P-gp介导白藜芦醇与乌苯美司发生药物相互作用的分子药代动力学机制，2015/01-2018/12，85万元，在研，参加。 3. 国家自然科学基金青年基金项目，81302838，常态及病态下药物转运体介导依普罗沙坦的药物相互作用及其分子药代动力学机制，2ᠦ୔

(1) Sun P, Liu K. Drug-drug interactions of angiotensin converting enzyme inhibitors mediated by metabolizing enzymes and transporters. Curr Drug Metab. 2018 Jul 30. doi: 10.2174/ 1389200219666180 730163953. (2) Wang H, Sun P*, Wang C, Meng Q, Liu Z, Huo X, Sun H, Ma X, Peng J, Liu K*. Pharmacokinetic changes of cefdinir and cefditoren and its molecular mechanisms in acute kidney injury in rats. J Pharm Pharmacol. 2018 Jul 25. doi: 10.1111/jphp.12994. (3) Hepeng Wang, Pengyuan Sun*, Changyuan Wang, Qiang Meng, Zhihao Liu, Xiaokui Huo, Huijun Sun, Xiaodong Ma, Jinyong Peng, Kexin Liu*. Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in human and Oatp1a1, Oatp1a4, Oatp1b2 in rat. RSC ADVANCES, 2017,7 (48): 30038-30048. (4) Jin H, Li Z, Takatori S, Koyama T, Jin X, Zamami Y, Kawasaki H, Sun P*. Vascular responses to compound 48/80 in rat mesenteric vascular beds. Can J Physiol Pharmacol. 2016 Jun;94(6):620-6. (5) Sun P, Wang C, Liu Q, Meng Q, Zhang A, Huo X, Sun H, Liu K. OATP and MRP2-mediated hepatic uptake and biliary excretion of eprosartan in rat and human. Pharmacol Rep. 2014 Apr;66(2):311-9. (6) Sun P, Takatori S, Jin X, Koyama T, Tangsucharit P, Li S, Zamami Y, Kitamura Y, Kawasaki H. Histamine H(3) receptor-mediated modulation of perivascular nerve transmission in rat mesenteric arteries. Eur J Pharmacol. 2011 Mar 25;655(1-3):67-73. (7) Sun P, Jin X, Koyama T, Li S, Kitamura Y, Kawasaki H. R-(-)-alpha-methylhistamine, a histamine H3 receptor agonist, induces endothelium-dependent vasodilation in rat mesenteric resistance arteries. Biol Pharm Bull. 2010;33(1):58-63.